Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas

Cancer Research

Volumn 63, Issue 1, 2003, Pages 60-66

  Kobayashi, Tohru ^a   Yamaguchi, Motoko ^a   Kim, Seungchan ^b   Morikawa, Jun ^a   Ogawa, Shoko ^a   Ueno, Satoshi ^a   Suh, Edward ^b   Dougherty, Edward ^b   Shmulevich, Ilya ^b   Shiku, Hiroshi ^a   Zhang, Wei ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD36 ANTIGEN; CD5 ANTIGEN; CELL SURFACE MARKER; COMPLEMENTARY DNA; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; UNINDEXED SEQUENCE; VASCULAR ENDOTHELIUM;

AGED; AGED, 80 AND OVER; ANTIGENS, CD5; BLOOD VESSELS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VON WILLEBRAND FACTOR;

EID: 0037229674     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. H segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphoma. Jpn. J. Cancer Res., 88: 1087-1093, 1997.
2. + diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood, 91: 1145-1151, 1998.
3. Nakamura, N., Hashimoto, Y., Kuze, T., Tasaki, K., Sasaki, Y., Sato, M., and Abe, M. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma. Lab. Investig., 79: 925-933, 1999.
4. Bums, B. F., Warnke, R. A., Doggett, R. S., and Rouse, R. V. Expression of a T-cell antigen (Leul) by B-cell lymphomas. Am. J. Pathol., 113: 165-171, 1983.
5. Matolcsy, A., Chadbum, A., and Knowles, D. M. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am. J. Pathol., 147: 207-216, 1995.
6. Yamaguchi, M., Ohno, T., Oka, K., Taniguchi, M., Ito, M., Kita, K., and Shiku, H. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br. J. Haematol., 105: 1133-1139, 1999.
7. Yamaguchi, M., Seto, M., Okamoto, M., Ichinohasama, R., Nakamura, N., Yoshino, T., Suzumiya, J., Murase, T., Miura, I., Akasaka, T., Tamaru, J., Suzuki, R., Kagami, Y., Hirano, M., Morishima, Y., Ueda, R., Shiku, H., and Nakamura, S. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood, 99: 815-821, 2002.
8. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R., Wilson, W., Grever, M. R., Byrd, J. C., Botstein, D., Brown, P. O., and Staudt, L. M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
9. Kim, S., Dougherty, E. R., Barrera, J., Chen, Y., Bittner, M. L., and Trent. J. M. Strong feature sets from small samples. J. Comput. Biol., 9: 129-148, 2002.
10. Jaffe, E. S., Harris, N. L., Stein, H., Vardiman, J. W., (Eds.). Pathology and Genetics, WHO Classification of Tumours, Tumours of Haematopoietic and Lymphoid Tissues, pp. 119-187. Lyon: IARC Press, 2001.
11. Taylor, E., Cogdell, D., Coombes, K., Hu, L., Ramdas, L., Tabor, A., Hamilton, S., and Zhang, W. Sequence verification as quality control step for production of cDNA microarray. Biotechniques, 31: 62-65, 2001.
12. Hu, L., Wang, J., Baggerly, K., Wang, H., Fuller, G. N., Hamilton, S. R., Coombes, K. R., and Zhang, W. Obtaining reliable information from minute amounts of RNA using cDNA microarrays. BMC Genomics, 3: 16, 2002.
13. Shmulevich, I., Hunt, K., El-Naggar, A., Taylor, E., Ramdas, L., Laborde, P., Hess, K. R., Pollock, R., and Zhang, W. Tumor specific gene expression profiles in human leiomyosarcoma: an evaluation of int-tumor heterogeneity. Cancer (Phila.), 94: 2069-2075, 2002.
14. Oka, K., Ohno, T., Kita, K., Yamaguchi, M., Takakura, N., Nishii, K., Miwa, H., and Shirakawa, S. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br. J. Haematol., 86: 786-791, 1994.
15. Suzuki, R., Takemura, K., Tsutsumi, M., Nakamura, S., Hamajima, N., and Seto, M. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma. Am. J. Pathol., 159: 425-429, 1995.
16. Yin, Z., Giacomello, E., Gabriele, E., Zardi, L., Aota, S., Yamada, K. M., Skerlavaji, B., Doliana, R., Colombatti, A., and Perris, R. Cooperative activity of α4β1 and α4β7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain. Blood, 93: 1221-1230, 1999.
17. Stroeken, P. J., van Rijthoven, E. A., van der Valk, M. A., and Roos, E. Targeted disruption of the β1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity. Cancer Res., 58: 1569-1577, 1998.
18. Terol, M. J., Lopez-Guillermo, A., Bosch, F., Villamor, N., Cid. M. C., Campo, E., and Montserrat, E. Expression of β-integrin adhesion molecule in non-Hodgkin's lymphoma: correlation with clinical and evolutive features. J. Clin. Oncol., 17: 1869-1875, 1999.
19. Corcoran, L. M., Karvelas. M., Nossal, G. J. V., Ye, Z-S., Jacks, T., and Baltimore, D. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev., 7: 570-582, 1993.
20. Ruttella, S., Rumi, C., Di Mario, A., and Leone, G. Expression of thrombospondin receptor (CD36) in chronic B-cell lymphoproliferative disorders: a role of tumor metastasis. Eur. J. Histochem., 41(Suppl. 2): 53-54, 1997.
21. Rutella, S., Rumi, C., Puggioni, P., Barberi, T., Di Mario, A., Larocca, L. M., and Leone, G. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Haematologica, 84: 419-424, 1999.
22. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., and Kinzler, K. W. Genes expressed in human tumor endothelium. Science (Wash. DC), 289: 1121-1122, 2000.
23. Thorne, R. F., Marshall, J. F., Shafren, D. R., Gibson, P. G., Hart, I. R., and Burns, G. F. The integrins a3b1 and a6b1 phisically and functionally associate with CD36 in human melanoma cells. J. Biol. Chem., 275: 35264-35275, 2000.